DODGX | HFCVX | DODGX / HFCVX | |
Total Expense Ratio | 0.51 | 1.22 | 42% |
Annual Report Gross Expense Ratio | 0.51 | 1.22 | 42% |
Fund Existence | 60 years | 29 years | - |
Gain YTD | 3.642 | 8.898 | 41% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 292M | 39,041% |
Annual Yield % from dividends | 1.40 | 3.08 | 45% |
Returns for 1 year | 5.93 | 13.82 | 43% |
Returns for 3 years | 28.15 | 19.30 | 146% |
Returns for 5 years | 72.42 | 76.58 | 95% |
Returns for 10 years | 53.93 | 46.58 | 116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LHCQX | 17.93 | -0.10 | -0.55% |
Lord Abbett Health Care R3 | |||
JLCVX | 70.98 | -0.89 | -1.24% |
JHancock Fundamental Large Cap Core R5 | |||
TRGVX | 18.21 | -0.23 | -1.25% |
T. Rowe Price Glbl Val Eq | |||
GSMGX | 13.37 | -0.23 | -1.69% |
Goldman Sachs Small/Mid Cap Growth C | |||
RPMFX | 15.11 | -0.34 | -2.20% |
Reinhart Genesis PMV Advisor |